| References: |
Potent, selective, competitive ORL1 non-peptide agonist. Displays 1000-fold selectivity over classical opioid receptors. IC50 values for receptor subtypes are 0.27 (ORL1), 6700 (μ), 2500 (κ) and >10000 (δ) nM. Systemic administration alleviates experimental Parkinson's in rats. For the detailed information of BAN ORL 24, the solubility of BAN ORL 24 in water, the solubility of BAN ORL 24 in DMSO, the solubility of BAN ORL 24 in PBS buffer, the animal experiment (test) of BAN ORL 24, the cell expriment (test) of BAN ORL 24, the in vivo, in vitro and clinical trial test of BAN ORL 24, the EC50, IC50,and affinity,of BAN ORL 24, For the detailed information of BAN ORL 24, the solubility of BAN ORL 24 in water, the solubility of BAN ORL 24 in DMSO, the solubility of BAN ORL 24 in PBS buffer, the animal experiment (test) of BAN ORL 24, the cell expriment (test) of BAN ORL 24, the in vivo, in vitro and clinical trial test of BAN ORL 24, the EC50, IC50,and affinity,of BAN ORL 24, Please contact DC Chemicals. |
